SCHEMBL6553375

SCHEMBL6553375

CCS(=O)(=O)N[C@H](C(=O)NCCc1ccc(O)c(OC)c1)C(C)C

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.50
LMNA P02545 1/20 0.50
MTNR1A P48039 1/20 0.50
MTNR1B P49286 1/20 0.50
ALOX5 P09917 1/20 0.48
OR51E2 Q9H255 1/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
NOX4 Q9NPH5 1/20 0.46
FOS P01100 1/20 0.46
TTR P02766 1/20 0.46
JUN P05412 1/20 0.46
NR3C1 P04150 1/20 0.46
HSD17B1 P14061 1/20 0.46
HSD17B2 P37059 1/20 0.46
TYR P14679 1/20 0.46
ACHE P22303 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6553382 1.00 SMN1; SMN2 (0.50) SMN1; SMN2LMNAMTNR1AMTNR1BALOX5
SCHEMBL6556807 0.90 MTNR1A (0.51) SMN1; SMN2LMNAMTNR1AMTNR1BALOX5
SCHEMBL7103339 0.89 MEN1 (0.57) SMN1; SMN2LMNAALOX5MEN1KMT2A
SCHEMBL7103335 0.89 MEN1 (0.57) SMN1; SMN2LMNAALOX5MEN1KMT2A
SCHEMBL7896834 0.83 SMN1; SMN2 (0.48) SMN1; SMN2LMNAMEN1KMT2A
SCHEMBL7896831 0.83 SMN1; SMN2 (0.48) SMN1; SMN2LMNAMEN1KMT2A
SCHEMBL7605247 0.83 MTNR1A (0.56) SMN1; SMN2LMNAMTNR1AMTNR1BMEN1
SCHEMBL7670246 0.83 SMN1; SMN2 (0.49) SMN1; SMN2LMNAMEN1KMT2A
SCHEMBL7021547 0.83 TRPV1 (0.43) SMN1; SMN2LMNAALOX5MEN1KMT2A
SCHEMBL7021554 0.83 TRPV1 (0.43) SMN1; SMN2LMNAALOX5MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1135369-B1 ALPHA-SULFIN- AND ALPHA-SULFONAMINO ACID AMIDES SYNGENTA PARTICIPATIONS AG (CH) 2004-02-25 EP disclosed
US-6538159-B2 For use in protecting plants against infestation by phytopathogenic microorganisms SYNGENTA PARTICIPATIONS AG (CH) 2003-03-25 US disclosed
EP-0968179-B1 N-SULPHONYL AND N-SULPHINYL AMINO ACID AMIDES AS MICROBIOCIDES SYNGENTA PARTICIPATIONS AG (CH) 2002-09-25 EP disclosed
US-20020099241-A1 For use in protecting plants against infestation by phytopathogenic microorganisms SYNGENTA PARTICIPATIONS AG (CH) 2002-07-25 US disclosed
EP-1135369-A2 ALPHA-SULFIN- AND ALPHA-SULFONAMINO ACID AMIDES Syngenta Participations AG (CH) 2001-09-26 EP disclosed
US-6277849-B1 FOR PROTECTION OF PLANTS AGAINST PHYTOPATHOGENIC MICROORGANISM INFESTATION SYNGENTA CROP PROTECTION, INC. 2001-08-21 US disclosed
US-6194611-B1 FOR CONTROLLING OR PREVENTION OF PLANT INFESTATION BY PHYTOPATHOGENIC MICROORGANISMS, SUCH AS FUNGI NOVARTIS CROP PROTECTION, INC. 2001-02-27 US disclosed
WO-2000032569-A2 ALPHA-SULFIN- AND ALPHA-SULFONAMINO ACID AMIDES SYNGENTA PARTICIPATIONS AG (CH) 2000-06-08 WO disclosed
EP-0858448-B1 N-SULPHONYL AND N-SULPHINYL AMINO ACID DERIVATIVES AS MICROBICIDES NOVARTIS AG (CH) 2000-05-31 EP disclosed
EP-0968179-A1 N-SULPHONYL AND N-SULPHINYL AMINO ACID AMIDES AS MICROBIOCIDES Novartis AG (CH) 2000-01-05 EP disclosed
WO-1998038161-A1 N-SULPHONYL AND N-SULPHINYL AMINO ACID AMIDES AS MICROBIOCIDES NOVARTIS AG (CH) 1998-09-03 WO disclosed
EP-0858448-A1 N-SULPHONYL AND N-SULPHINYL AMINO ACID DERIVATIVES AS MICROBICIDES Novartis AG (CH) 1998-08-19 EP disclosed
WO-1997014677-A1 N-SULPHONYL AND N-SULPHINYL AMINO ACID DERIVATIVES AS MICROBICIDES NOVARTIS AG (CH) 1997-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020099241-A1 For use in protecting plants against infestation by phytopathogenic microorganisms CBR1, CBR3, MSR1 SMN1; SMN2 3433/4885LMNA 3204/4885MTNR1A 322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.